Cryo-Cell International Inc. (CCEL)
CCEL trades on NYSE in Health Care, Misc Health and Biotechnology Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$4.30
-4.44% on the day
Market cap
$34.7M
Nano cap
Revenue · 2025
$31.6M
No prior year to compare
Net income · 2025
-$2.4M
-7.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), period ending 2025-11-30, https://www.sec.gov/Archives/edgar/data/862692/000119312526083096/0001193125-26-083096-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), period ending 2025-11-30.
Profile
| Field | Value |
|---|---|
| Ticker | CCEL on NYSE |
| Sector | Health Care |
| Industry | Misc Health and Biotechnology Services |
| Country | United States |
| IPO year | 2022 |
| SEC CIK | 0000862692 |
| SEC industry code | Services-Misc Health & Allied Services, NEC |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $31.6M |
| Net income | -$2.4M |
| Operating income | $482K |
| Net margin | -7.7% |
| Operating margin | 1.5% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $319K |
| Total assets | $61.7M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.1× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-1/A | 2022-04-28 |
| Latest annual report | 10-K | 2026-02-27 |
| Latest quarterly / interim | 10-Q | 2026-10-09 |
| Latest current report | 8-K | 2026-09-14 |
| Latest proxy | DEF 14A | 2026-10-13 |
Source: SEC EDGAR submissions feed, 905 recent filings. All filings on EDGAR.
Peers in Misc Health and Biotechnology Services
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PARK | Park Dental Partners Inc. | $19.59 | -3.31% | $93.2M |
| MGRX | Mangoceuticals Inc. | $0.3716 | -3.08% | $8.3M |
| VMD | Viemed Healthcare Inc. Common Shares | $9.61 | +0.10% | $366.0M |
| NIVF | NewGenIvf Group Limited | $0.1954 | -17.24% | $1.7M |
| AGL | agilon health inc. | $85.90 | +0.48% | $1.4B |
| PGNY | Progyny Inc. | $27.39 | -2.28% | $2.1B |
| SHC | Sotera Health Company | $18.21 | +0.33% | $5.2B |
| DVA | DaVita Inc. | $182.08 | +0.17% | $11.6B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier